6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neurotoxicity of Methamphetamine Use
Methamphetamine use can cause significant neurotoxicity, leading to long-term cognitive and behavioral impairments. This substance damages dopamine and serotonin systems in the brain, which are vital for mood regulation, reward processing, and motor function. Chronic methamphetamine exposure often results in oxidative stress and inflammation, further harming neural structures. Structural changes in brain regions, such as the prefrontal cortex and basal ganglia, are commonly observed, impairing decision-making and impulse control. These neurotoxic effects can persist even after prolonged abstinence, though some recovery may occur with time and therapeutic interventions. Addressing neurotoxicity through treatments like cognitive rehabilitation and antioxidant therapies is essential for improving the quality of life in affected individuals.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Michelle Charbonnier
MoNetwork, United States
Monica Zuniga Fajuri
Tiburcio Vasquez Health Center, United StatesSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States